Cargando…

Immunologic and Protective Properties of Subunit- vs. Whole Toxoid-Derived Anti-Botulinum Equine Antitoxin

Botulism is a paralytic disease caused by botulinum neurotoxins (BoNTs). Equine antitoxin is currently the standard therapy for botulism in human. The preparation of equine antitoxin relies on the immunization of horses with botulinum toxoid, which suffers from low yield and safety limitations. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben David, Alon, Barnea, Ada, Torgeman, Amram, Diamant, Eran, Dor, Eyal, Schwartz, Arieh, Rosen, Osnat, Caspi, Noa, Saraf, Miki, Lerer, Elad, Adar, Yaakov, Lupo, Edith, Toister, Einat, Zichel, Ran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506527/ https://www.ncbi.nlm.nih.gov/pubmed/36146601 http://dx.doi.org/10.3390/vaccines10091522

Ejemplares similares

Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model
por: Torgeman, Amram, et al.
Publicado: (2018)

Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E
por: Ben David, Alon, et al.
Publicado: (2021)

A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism
por: Torgeman, Amram, et al.
Publicado: (2021)

Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations
por: Torgeman, Amram, et al.
Publicado: (2017)

A Rabbit Model for Prolonged Continuous Intravenous Infusion Via a Peripherally Inserted Central Catheter
por: Dor, Eyal, et al.
Publicado: (2021)

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs
por: Diamant, Eran, et al.
Publicado: (2015)

Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
por: Rosen, Osnat, et al.
Publicado: (2016)

Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries
por: David, Alon Ben, et al.
Publicado: (2021)

Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography
por: Lerer, Elad, et al.
Publicado: (2021)

High Cell Density Cultivation Process for the Expression of Botulinum Neurotoxin a Receptor Binding Domain
por: Ben David, Alon, et al.
Publicado: (2022)

Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope
por: Mechaly, Adva, et al.
Publicado: (2022)

Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate
por: Makovitzki, Arik, et al.
Publicado: (2021)

Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E
por: Rosen, Osnat, et al.
Publicado: (2017)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

Evaluating the Synergistic Neutralizing Effect of Anti-Botulinum Oligoclonal Antibody Preparations
por: Diamant, Eran, et al.
Publicado: (2014)

Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry
por: Madmon, Moran, et al.
Publicado: (2022)

Centaur antibodies: Engineered chimeric equine-human recombinant antibodies
por: Rosenfeld, Ronit, et al.
Publicado: (2022)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : VI. FURTHER INVESTIGATIONS ON THE IDENTITY AND SPECIFICITY OF NON-PRECIPITATING SKIN-SENSITIZING ANTITOXIN
por: Kuhns, William J.
Publicado: (1955)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : II. A COMPARISON BETWEEN THE IMMUNOLOGICAL PROPERTIES OF PRECIPITATING AND NON-PRECIPITATING (SKIN-SENSITIZING) ANTITOXINS
por: Kuhns, William J., et al.
Publicado: (1952)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : IV. DIFFERENCES BETWEEN HUMAN PRECIPITATING AND NON-PRECIPITATING SKIN-SENSITIZING DIPHTHERIA ANTITOXIN AS SHOWN BY ELECTROPHORESIS
por: Kuhns, William J.
Publicado: (1954)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : III. STUDIES OF THE PASSIVE ARTHUS REACTION IN GUINEA PIGS USING HUMAN PRECIPITATING AND NON-PRECIPITATING DIPHTHERIA ANTITOXIN
por: Kuhns, William J.
Publicado: (1953)

In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel Technique
por: Makovitzki, Arik, et al.
Publicado: (2021)

THE PURIFICATION AND CONCENTRATION OF DIPHTHERIA TOXOID
por: Wadsworth, Augustus, et al.
Publicado: (1932)

Post-Exposure Anti-Ricin Treatment Protects Swine against Lethal Systemic and Pulmonary Exposures
por: Falach, Reut, et al.
Publicado: (2020)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021)

Antitoxine
por: Browne, Lennox
Publicado: (1895)

Antitoxin
Publicado: (1896)

Antitoxin
Publicado: (1895)

Antitoxin
Publicado: (1897)

Nutrient Status of Cucumber Plants Affects Powdery Mildew (Podosphaera xanthii)
por: Elad, Yigal, et al.
Publicado: (2021)

Effect of Mineral Nutrition and Salt Spray on Cucumber Downy Mildew (Pseudoperonospora cubensis)
por: Barnea, Dor, et al.
Publicado: (2022)

PREPARATION AND PROPERTIES OF SHIGA TOXIN AND TOXOID
por: Dubos, René J., et al.
Publicado: (1946)

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

The Relation of Toxoid Dilution to Immunizing Capacity
por: Bliss, Joseph A.
Publicado: (1938)

Cholera Antitoxine
por: Powell, Arthur
Publicado: (1896)

Antitoxine in Diphtheria
por: Moir, D. M.
Publicado: (1895)

Diphtheria and Antitoxin
por: Hanson, A. S.
Publicado: (1895)

Antitoxin at Colchester
Publicado: (1902)

The Dose of Antitoxins
por: O'Gorman, P. W.
Publicado: (1903)

Cannot write session to /tmp/vufind_sessions/sess_21tefcen1c10doitqgrfb8hcao